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Abstract
Background: Malignant thymomas are rarely associated with bone metastasis and T-cell lymphocytosis.
Case presentation: A 47–year-old female patient was admitted to our hospital for ptosis. A diagnosis of malignant
thymoma was made based on the thymectomy and pathological result. Peripheral T-cell lymphocytosis and bone
metastasis were found later. T-cell lymphocytosis was relived after surgical and radiation therapy to the metastasis.
Conclusion: Peripheral T-cell lymphocytosis is a rare paraneoplastic phenomenon associated with thymomas. This
report is the first to describe an invasive thymoma with late bone metastasis accompanied with T-cell
lymphocytosis. We should be aware of peripheral T-cell lymphocytosis in thymomas and it may contribute to a
better understanding of the complex physiology and pathogenesis of thymoma.
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Background
Thymomas are rare anterior mediastinal tumors, which
originate from the thymic epithelial cells. According to
the pathologic classification developed by the World
Health Organization, thymomas are classified into five
groups (type A, AB, B1, B2 and B3) by predominate cell
type. Thymomas are usually slow growing with more
local recurrence rather than metastasis. Sporadic cases
with late distant metastasis, including lungs, pleura, liver,
thyroid and bones, have been reported [1].
The thymus gland is responsible for the maturation of
T-lymphocyte and some other immunologic function.
Thus, the neoplastic thymoma is associated with an
array of “paraneoplastic” syndromes such as myasthenia
gravis, pure cell aplasia, hypogammagloulinemia. How-
ever, T-cell lymphocytosis in peripheral blood is an ex-
tremely rare phenomeon.
We report a 47-year-old female patient with a previous
history of myasthenia gravis (MG) and malignant thym-
oma, who developed thoracic vertebrae and paravertebrae
metastasis associated T-cell lymphocytosis.
Case presentation
A 47–year-old female patient was admitted to our hos-
pital in 2007 for ptosis. Laboratory tests showed higher
percentage of the lymphocytes (77.5 %) with 4.45 × 109/L
leukocytes and 3.45 × 109/L lymphocytes. A chest com-
puted tomography scan showed an 11 cm × 9 cm × 9 cm
irregular solid mass in the anterior mediastinum, with
infiltration of the diaphragm and left chest wall. She was
diagnosed with MG and a mediastinal mass. Thymec-
tomy detected a mediastinal mass infiltrating the peri-
cardium and left pleura and penetrating the left lung. In
addition, second mass was found adherent to the left
diaphragm. Both tumors were resected and histologically
classified as malignant thymoma (type AB) with infiltra-
tion of chest wall, diaphragm, pericardium, left pleura and
lung. Regional nodules were resected and showed lymph-
adenitis. The patient received ADOC chemotherapy
(Cyclophosphamide, Doxorubicin, Cisplatin, Vincristine)
and radiation therapy after surgery and followed up with a
relief of MG.
The patient followed up with chest CT every year and
local recurrence in the left pleura was found in April,
2010. Unfortunately, the patient was found to have per-
ipheral T-cell lymphocytosis in 2014. Peripheral blood
analysis showed mild lymphocytosis (5.3 × 109/L), with
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Lymphocytes representing 60.7 % of the peripheral blood
leukocytes. Flow cytometric analysis revealed that most
of the lymphocytes were mature CD3+ CD5 + CD7+ T
cells. Moreover, bone marrow aspiration and biopsy
showed normal cellular counts and percentage.
The patient developed back pain and progressive lower
extremity weakness in August 2015. She also complained
of hypesthesia of lower limbs with urine incontinence.
The thoracic magnetic resonance imaging (MRI) showed
a paravertebral mass between T9 to T12 level with spinal
cord compression (Fig. 1). Laboratory tests showed
mild leukocytosis (11.29 × 109/L) with lymphocytosis
(9.29 × 109/L). We performed posterior decompression,
tumor resection with bone cement reconstruction and in-
ternal fixation emergently. Immediately after the oper-
ation, the patient’s peripheral lymphocyte count decreased
markedly from 5.61 × 109/L preoperatively to 1.77 × 109/L.
However, the lymphocyte count increased gradually to
13.97 × 109/L 4 days after surgery, and remained elevated
till discharge. One month later, she received radiation
therapy again and the lymphocytosis resolved during the
therapy (Fig. 2). The pathology reported malignant thym-
oma (type B2, locally B3), and her muscle strength and
urinary function recovered gradually.
Discussion
Thymomas are one of the most common tumors in the
anterior mediastinum. Malignant thymomas are usually
determined by the invasiveness into nearby tissues or
distant metastasis. The recurrence of thymomas is rare,
and distant metastasis is reported by only a few cases [1].
In the present study, the patient was diagnosed with ma-
lignant thymoma with diaphragm and pleural infiltration
at the onset. Interestingly the pathology classified the
thymoma into type AB from the onset but progressed into
type B2/B3 in the bone metastasis 8 years later. We hy-
pothesized that the biological behavior of thymomas
might have changed or progressed during time.
On rare occasions peripheral T-cell lymphocytosis is
associated with malignant thymomas. Only a few cases
have been reported, but the mechanism has not been
well described until now. For example, Pedraza et al. re-
ported the first case in 1977 [2], and Barton reviewed
seven similar cases in 1997 [3]. A few more cases were
reported after then (Table 1). It seems that females were
more likely to suffer from this situation than males,
which may help us to clarify the mechanism. In all these
cases, T-cell lymphocytosis was asscociated with aggres-
sive thymomas, and most of them were relived after
surgery or chemo/radiation therapy. On these conditions,
lymphoproliferative diseases should be first excluded, al-
though it is more rarely coexist with thymomas. In our
case, the flow cytometric study showed a polyclonal T-cell
population. The bone marrow examination also excluded
bone marrow lymphocytosis as well as lymphocytic
leukemia. Therefore, we concluded that the T-cell lym-
phocytosis originated from peripheral.
In our case, the percentage of lymphocyte was higher
than normal in 2007, and T-cell lymphocytosis was diag-
nosed in 2013. No therapy was conducted until the
Fig. 1 Preoperative T2-weighted magnetic resonance images of thoracic spine. a. sagittal image revealed a paravertebral mass between T9 and
T12 level. b. coronal image of T7 vertebrae showed pleural mass. c. coronal image of T10 vertebrae showed spinal compression
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patient developed lower limb weakness. Interestingly, T-
cell lymphocytosis got relived immediately after the re-
moval of the vertebral tumor. However the lymphocyte
count elevated 4 days later. The radiation therapy was
done and the lymphocyte counted decreased to normal
again. Therefore, we concluded that T-cell lymphocytosis
was associated with malignant thymoma in this case. Pre-
vious cases showed that most T-cell lymphocytosis was
relived after tumor resection or chemotherapy/irradiation,
indicating that lymphocytosis might be one of the para-
neoplastic phenomena of thymoma. In addition, T-cell
lymphocytosis may be a prediction whether the thymoma
is sensitive to the therapy.
However, the mechanism has not been fully elucidated.
In most cases T-cell lymphocytosis quickly resolved after
surgical resection and/or chemo/radiotherapy. Earlier
Fig. 2 Variation of peripheral leucocytes and lymphocyte count
Table 1 Case review
Author, year Presentation Invasive or metastasis Peripheral lymphocytes Therapy Outcome
Pedraza, 1977 [2] 69y/male Left pleura 15,000 leukocytes with
70 % lymphocytes
Surgery/radiotherapy Resolved
Griffin et al., 1978 [5] 64y/female N/A 25,000 leukocytes with
52 % lymphocytes
Biopsy/chemotherapy Resolved






















Barton, 1997 [3] 35y/female Right pleura 20,100 leukocytes with
57 % lymphocytes
Surgery/radiotherapy Resolved
Otton SH et al.2000 [8] 71y/male N/A 6500 lymphocytes Steroids & azathioprine Not resolved







Chen HK et al., 2009 [10] 62y/female Lung 18,000 leukocytes with
77.4 % lymphocytes
Surgery Resolved
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studies indicated a spillover from the lymphocyte-rich
thymoma into the peripheral blood [3]. However, later
studies found differences between the immunopheno-
type of the cells in thymoma and the peripheral T-cells.
Given that the immunophenotypes of circulating lym-
phocytes were polyclonal mature T cells, these cells were
postulated to derive from the spillage of intratumoral
lymphocytes into the circulation or a reactive prolifera-
tion of peripheral lymphocytes, which was related to
deregulated, thymoma-associated immunoresponse. Me-
deiros suggested there was an immunoregulatory dis-
order mediated by thymic hormone released by the
tumor. Most authors now agree that there may be a
physiologic imbalances with malignant thymic cells,
which lead to immune disorders and finally to impaired
proliferation, maturation, and migration of T-cells [4].
Conclusion
Peripheral T-cell lymphocytosis is a rare paraneoplastic
phenomenon associated with thymomas. We propose
that female sex, lymphocyte-rich thymomas that behaved
aggressively and invasively may be the risk factors in the
majority of cases. As far as we know, our report is the
first to describe an invasive thymoma with late bone me-
tastasis accompanied with T-cell lymphocytosis. Clinicians
should be aware of peripheral T-cell lymphocytosis in
thymomas, although it is a rare manifestation of thym-
omas. It contributes to a better understanding of the com-
plex physiology and pathogenesis of thymoma. Moreover,
further studies are needed to investigate the relationship
between T-cell lymphocytosis and thymoma.
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